Investor insights
Sectors invested in
Contract Manufacturing1
Biotechnology1
Association1
Contract Research1
Non Profit1
Manufacturing1
Antibody Drug Conjugates1
Monoclonal Antibody Therapeutics1
Funding rounds participated in
$59M sweet spot round size
Most of their 1 investments are in rounds between $59M and $59M
Basic info
Industry
biotechnology research
Sectors
Biotechnology
Pharmaceutical
monoclonal antibodies
oncology
targeted therapies
cancer immunotherapy
clinical trials
Health Care
Date founded
2015
Investments made
M
MabPlex International Co., Ltd. raised $59M on January 17, 2019
Investors: ANTAGENE, 深圳裕策生物科技有限公司, 澳斯康生物制药Thousand Oaks Biopharmaceuticals, Shenzhen Capital Group Co., Ltd, Apic Bio, Inc. and Apollomics
Funding rounds raised
Total raised
$124M
from 5 investors over 5 rounds
A
Apollomics raised $124M on November 5, 2020
Investors: 平安资本
A
Apollomics raised $100M on January 8, 2019
Investors: K2VC 险峰, CMB International and OrbiMed Advisors
A
Apollomics raised $9.8M on August 29, 2016
Investors: OrbiMed Advisors